Hisamitsu Pharmaceutical Co., Inc. (HTSUF)
OTCMKTS · Delayed Price · Currency is USD
29.00
+0.06 (0.21%)
At close: Aug 21, 2025
HTSUF Revenue
Hisamitsu Pharmaceutical Co. had revenue of 39.57B JPY in the quarter ending November 30, 2025, with 10.54% growth. This brings the company's revenue in the last twelve months to 159.27B, up 6.08% year-over-year. In the fiscal year ending February 28, 2025, Hisamitsu Pharmaceutical Co. had annual revenue of 156.01B with 10.09% growth.
Revenue (ttm)
159.27B JPY
Revenue Growth
+6.08%
P/S Ratio
2.83
Revenue / Employee
56.90M JPY
Employees
2,799
Market Cap
2.89B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Feb 28, 2025 | 156.01B | 14.30B | 10.09% |
| Feb 29, 2024 | 141.71B | 13.38B | 10.42% |
| Feb 28, 2023 | 128.33B | 8.14B | 6.77% |
| Feb 28, 2022 | 120.19B | 5.68B | 4.96% |
| Feb 28, 2021 | 114.51B | -26.48B | -18.78% |
| Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
Hisamitsu Pharmaceutical Co. News
- 5 weeks ago - Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO - Reuters